As with any compounded medication, administration should be performed by qualified personnel familiar with sterile injection techniques and patient monitoring
Before the meeting, FDA scientists released briefing documents that strongly advised against making these peptides available due to lack of evidence and safety concerns, meaning the advisory committee went against their own experts
Another review of studies involving BPC-157, as well as TB-500, GHK-Cu, and several other peptides, similarly found a lack of evidence to support clinical use of the substances
For those eager to dive deeper into the art of creating stable and effective products, our blog is packed with resources
However, comprehensive long-term studies on human subjects taking BPC 157 are still limited, and potential risks cannot be ruled outwithout further systematic review
Why wait for tomorrow when you can start today